Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients-Reference-Cited by-同舟云学术

Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients

Published:2014-07-15 Issue:1 Volume:7 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Bartram Isabelle,Gökbuget Nicola,Schlee Cornelia,Heesch Sandra,Fransecky Lars,Schwartz Stefan,Stuhlmann Reingard,Schäfer-Eckhart Kerstin,Starck Michael,Reichle Albrecht,Hoelzer Dieter,Baldus Claudia D,Neumann Martin

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Biology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s13045-014-0051-y.pdf

Reference54 articles.

1. Gokbuget N, Hoelzer D: Treatment of adult acute lymphoblastic leukemia. Semin Hematol. 2009, 46: 64-75. 10.1053/j.seminhematol.2008.09.003.

2. Hunault M, Harousseau JL, Delain M, Truchan-Graczyk M, Cahn JY, Witz F, Lamy T, Pignon B, Jouet JP, Garidi R, Caillot D, Berthou C, Guyotat D, Sadoun A, Sotto JJ, Lioure B, Casassus P, Solal-Celigny P, Stalnikiewicz L, Audhuy B, Blanchet O, Baranger L, Béné MC, Ifrah N: Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. Blood. 2004, 104: 3028-3037. 10.1182/blood-2003-10-3560.

3. Bassan R, Hoelzer D: Modern therapy of acute lymphoblastic leukemia. J Clin Oncol. 2011, 29: 532-543. 10.1200/JCO.2010.30.1382.

4. Hoelzer D: Novel antibody-based therapies for acute lymphoblastic leukemia. Hematol Am Soc Hematol Educ Progr. 2011, 2011: 243-249. 10.1182/asheducation-2011.1.243.

5. Daver N, O'Brien S: Novel therapeutic strategies in adult acute lymphoblastic leukemia - a focus on emerging monoclonal antibodies. Curr Hematol Malig Rep. 2013, 8: 123-131. 10.1007/s11899-013-0160-7.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pivotal role of BCL11B in the immune, hematopoietic and nervous systems: a review of the BCL11B-associated phenotypes from the genetic perspective;Genes & Immunity;2024-03-12

2. Updates on lymphoblastic leukemia/lymphoma classification and minimal/measurable residual disease analysis;Seminars in Diagnostic Pathology;2023-11

3. T‐cell lymphoma patient harboring BCL11B mutations had favorable overall survival;Asia-Pacific Journal of Clinical Oncology;2023-08-27

4. Mapping the genetic features of T-ALL cases through simplified NGS approach;Clinical Immunology;2022-12

5. Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms;Pathology;2022-12